StockData
TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Trulieve Cannabis Corp.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$10.28+0.27 (+2.70%)

Close on Oct 19, 2026

Market cap
$1.98B
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q1 FY2026
Ended Mar 31, 2026
May 7, 2026Before market open$287.00M$0.02$0.10
Q4 FY2025
Ended Dec 31, 2025
Feb 26, 2026Before market open$293.00M$-0.23$-0.02
Q3 FY2025
Ended Sep 30, 2025
Nov 5, 2025Before market open$288.00M$-0.14$-0.07
Q2 FY2025
Ended Jun 30, 2025
Aug 6, 2025Before market open$302.00M––
Q1 FY2025
Ended Mar 31, 2025
May 7, 2025Before market open$298.00M––
Q4 FY2024
Ended Dec 31, 2024
Feb 27, 2025Before market open$301.00M$-0.26$0.02
Q3 FY2024
Ended Sep 30, 2024
Nov 5, 2024Before market open$284.00M$-0.32$-0.06
Q2 FY2024
Ended Jun 30, 2024
Aug 6, 2024Before market open$303.00M$-0.04$0.00
Q1 FY2024
Ended Mar 31, 2024
May 9, 2024Before market open–––
Q4 FY2023
Ended Dec 31, 2023
Feb 29, 2024Before market open–––
Q3 FY2023
Ended Sep 30, 2023
Nov 9, 2023Before market open–––
Q2 FY2023
Ended Jun 30, 2023
Aug 9, 2023Before market open–––

Press releases

Announcements Trulieve Cannabis filed with the SEC